US Patent Issued to Codexis on Aug. 5 for "Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs" (Singaporean, American Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,537, issued on Aug. 5, was assigned to Codexis Inc. (Redwood City, Calif.).

"Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs" was invented by Jovana Nazor (Milpitas, Calif.), Derek J. Smith (Singapore), Michael A. Crowe (Singapore), Shiwei Song (Singapore) and Steven J. Collier (Concord, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to pre...